Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Erin G. Reid, MD
University of California, San Diego
Study Chair - William Wachsman, MD
University of California, San Diego
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Ucla Clinical Aids Research and Education (care) Center
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- University of California at Davis Center for Aids Research and Education Services
Sacramento, California, United States
- University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, United States
- Emory Winship Cancer Institute
Atlanta, Georgia, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Northwestern Cancer Center
Chicago, Illinois, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- Thomas Street Health Center
Houston, Texas, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 31 Oct 2014
- Completion
- 30 Nov 2014
- Last update posted
- 10 Aug 2020
- Registered enrollment
- 23
- Registry id
- NCT00598169
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.